Inform
12345:False Friday, May 16, 2008
close
Submitting...
What can you do with My News?
Add any of your favorite news sources and read them all in place.
Track subjects in the news from across the web with unmatched precision.
Flag articles from anywhere on Inform and read them all from one list.

Create An Account

To save your settings permanently and use them on another computer, you must create a free user account.

There was an error creating your account. The email address you entered already exists in our system. Please enter a valid email address. Please enter a password at least 5 characters long. Your passwords do not match. Create

Already have an account? Log in.

Or, Try it First

You can try My News without creating an account.

Note: your settings will only be stored for 60 days and you can add a maximum of 5 items to My News.

Try It

Forgot your password?

There was an error with this request.

Enter your email address to have your password sent to you.

Submit
We've sent you your Inform password. Please check your email.
Publisher Services
Inform Publisher Services

Get more information about the services we provide to content publishers.

Demo
See the Inform.com demo

Take a quick tour of the features offered by Inform.com.

My News
Top Stories
Flagged Articles

Sources

Add

Thousands of your favorite news sources, all of their content, simply organized.

  1. x
    Edit
  2. x

Subjects

Add

Track subjects with unparalleled precision from news across the web.

  1. x
    Edit

Feeds

Add

Add any RSS feed.

  1. x
    Edit
View More Popular Subjects
Did you mean... ?
close
  1. • Biotechnology Sector

Biotechnology

sort by:
relevance
recency
Blogs
More Blogs
YouTube Mainstream Video / Audio
  • Loading...
  • There are no YouTube videos for this search.
  1. Currently, there are no results.
  2. Currently, there are no stories related to this story.
  3. Cambrex Appoints Steven M. Klosk as President and CEOExternal
    PharmaLive +My News 2 Hours Ago
    Cambrex , a leading life sciences company, announced today that the Board of Directors appointed Steven M. Klosk, President and Chief Executive …
  4. Opening Glance: BiotechnologyExternal
    Boston Globe +My News 1 Hour Ago
    Shares of large-cap biotechnology companies opened mostly higher Friday, as positive data abstracts from Genentech and ImClone started to be …
  5. Genetically modified human embryo stirs criticismExternal
    Boston Globe +My News 5/14/2008
    News that scientists have for the first time genetically altered a human embryo is drawing fire from some watchdog groups that say it's a step …
  6. Seattle Genetics Announces Upcoming SGN- 35 Presentation at the American Society of Clinical Oncology Annual MeetingExternal
    Drugs.com +My News 1 Hour Ago
    Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that SGN-35 phase I clinical data will be presented during a poster discussion session at the …
  7. Comment: Sports, technology and the meaning of ‘human’External
    Windsor Star +My News < 1 Hour Ago
    Thou, like a judge appointed for being honourable, art the moulder and maker of thyself; thou mayest sculpt thyself into whatever shape thou dost …
  8. Amgen Drug Reduces Spread of Cancer to Bones Better Than Rival TherapiesExternal
    Bloomberg +My News < 1 Hour Ago
    Amgen Inc.'s experimental drug denosumab was more effective than Novartis AG's Zometa in preventing fractures in cancer patients, according to …
  9. Haemacure Appoints Reinaldo M. Diaz to its Board of DirectorsExternal
    PharmaLive +My News 1 Hour Ago
    Haemacure Corporation , a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for …
  10. Industry Executives Finding Value in Shift of Scientific PublicationsExternal
    StreetInsider +My News < 1 Hour Ago
    The landscape of scientific publications strategy, planning and delivery is changing with the advent of transparency guidelines. Half of global …
  11. Cabinet calls for GMO- free agricultureExternal
    Swiss Info +My News 1 Hour Ago
    Voters approved a five-year blanket ban in a nationwide ballot in 2005, but research remains permitted. Parliament is to debate the government …
  12. Significant Anti- Tumor Activity of NKTR- 102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 ProceedingsExternal
    Drugs.com +My News 1 Hour Ago
    Nektar's Technology Enables First-Ever PEGylation of a Small Molecule with Demonstrated Therapeutic Activity Nektar Therapeutics announced initial …
  13. Accentia Biopharmaceuticals Reports Fiscal Second Quarter Financial ResultsExternal
    Genetic Engineering News +My News 1 Hour Ago
    Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that the Company has filed its Quarterly Report (Form 10-Q) with the SEC, reporting …
  14. Small- molecule startups attract execs, investorsExternal
    Mass High Tech +My News 1 Hour Ago
    Avila Therapeutics Inc. has been humming along without much notice for more than a year, steadily recruiting scientists and executives away from …
  15. Market Report - - Short Stories (RGDX)External
    MSN Money +My News 1 Hour Ago
    Response Genetics . Target $7.5 to $5. Caris downgrades RGDX to Above Average from Buy and lowers their tgt to $5 from $7.50 saying while they …
  16. Sterling- Hoffman Life Sciences Journal Spotlights CEO of Samaritan PharmaExternal
    PharmaLive +My News 1 Hour Ago
    Sterling-Hoffman Life Sciences Journal spotlights Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals (OTCBB:SPHC) …
  17. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) TrialExternal
    Genetic Engineering News +My News 1 Hour Ago
    VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular …
More Articles >

Sponsored Listings

©2008 Inform Technologies, LLC